Table 1.

Patient demographics (“as treated” population)a

CharacteristicNo. of Patients
N58
Age (yr)b
    mean31.1
    range17 to 62
Gender (male:female)56:2
Race (n [%])
    white53 (91)
    nonwhite5 (9)
ACEI/ARB use23 (40)
  • a ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers.

  • b At entry into the extension study.